This policy guidance provides recommendations for items that are available over the counter (OTC) and should not be routinely prescribed in primary care because: there is limited evidence of clinical ...
The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience.